Physician profile
Thomas Sibert
NPI 1710416243
$3,432.21
in general payments reported to CMS, 2019-2025
16 companies · $3,203 in 2025
The $3,203 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $229 · 2025: $3,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,043 · Food and Beverage: $1,215 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,043.49 |
| Food and Beverage | $1,215.11 |
| Education | $173.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,485.26 | 2025 | Indigo System |
| Genzyme Corporation | $271.76 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $230.48 | 2024-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $100.46 | 2024-2025 | Capvaxive |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Baxter Healthcare | $54.37 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Terumo Medical Corporation | $29.73 | 2025 | Metacross Otw |
| Insmed, INC. | $26.52 | 2025 | Arikayce |
| Philips North America LLC | $24.69 | 2024 | (9278) Bridge |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.43 | 2024 | Jardiance |
| Novo Nordisk INC | $21.87 | 2024 | |
| Abiomed | $20.57 | 2025 | |
| Verona Pharma, INC. | $18.43 | 2025 | Ohtuvayre |
| Astrazeneca Pharmaceuticals LP | $17.35 | 2025 | Lynparza |
| E.R. Squibb & Sons, L.L.C. | $15.81 | 2024 | Eliquis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.49 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Sibert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.